Avecho BiotechnologyAVEFF -74.14% Days Inventory is 70.48 as of Dec. 2025, which is 76% below its 10-year median of 291.22. The stock has 2 warning signs investors should review. Among 635 Biotechnology companies, Avecho Biotechnology ranks better than 72.13% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Avecho Biotechnology's Inventory Turnover for the
six
months ended in Dec. 2025 was 2.59.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Avecho Biotechnology's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.10.
Avecho Biotechnology (OTCPK:AVEFF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Avecho Biotechnology's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Avecho Biotechnology's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Avecho Biotechnology Days Inventory Related Terms
Avecho Biotechnology Days Inventory Historical Data
* Premium members only.
The historical data trend for Avecho Biotechnology's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AVEFF vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Avecho Biotechnology's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avecho Biotechnology Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Avecho Biotechnology's Days Inventory distribution charts can be found below:
* The bar in red indicates where Avecho Biotechnology's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avecho Biotechnology (AVEFF) has a Days Inventory of 70.48 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Avecho Biotechnology and its competitors. This is 76% below median its historical median of 291.22. Over the past decade, Avecho Biotechnology's Days Inventory has ranged from 75.82 to 1,038.09. According to the industry distribution chart, Avecho Biotechnology ranks #177 out of 635 companies in the Biotechnology industry, placing it in the top 27.9%.
Is Avecho Biotechnology's Days Inventory too high?
Avecho Biotechnology's current Days Inventory of 70.48 is 76% below median its 10-year median of 291.22. Over the past 10 years, this metric has ranged from a low of 75.82 to a high of 1,038.09. The Biotechnology industry median Days Inventory is 183.23. Avecho Biotechnology's value of 70.48 is 61.5% below this industry median. Based on the distribution chart, Avecho Biotechnology ranks #177 out of 635 companies in the Biotechnology industry, which is above the industry midpoint.
How does Avecho Biotechnology's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Avecho Biotechnology ranks #177 out of 635 companies for Days Inventory. This puts Avecho Biotechnology in the upper half of its industry. The industry median Days Inventory is 183.23. Avecho Biotechnology's value of 70.48 is 61.5% below this benchmark. Historically, Avecho Biotechnology's own Days Inventory has ranged from 75.82 to 1,038.09 over the past decade. While the company's 10-year median is 291.22 vs. the industry median of 183.23, Avecho Biotechnology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.23, based on 635 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avecho Biotechnology's current Days Inventory of 70.48 is 61.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Avecho Biotechnology and its competitors. For the Biotechnology industry, the median Days Inventory is 183.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avecho Biotechnology's current Days Inventory is 70.48, which is 76% below median its own 10-year median of 291.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avecho Biotechnology stock overvalued right now?
Avecho Biotechnology (AVEFF) has a current Days Inventory of 70.48. The current Days Inventory is 70.48, which is 76% below median its 10-year median of 291.22 and 61.5% below the Biotechnology industry median of 183.23. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Avecho Biotechnology (AVEFF), the current Days Inventory is 70.48 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sales, and licensing of products incorporating its patented platform technology Tocopheryl Phosphate Mixture (TPM), for the pharmaceutical, skincare, and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches, including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVEFF has been successfully added to your 